deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT03039621

Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children

International Multicenter Double-blind Placebo-Controlled Parallel-Group Randomized Clinical Trial of Efficacy and Safety of Ergoferon in the Treatment of Acute Respiratory Viral Infections in Children

Sponsor: Materia Medica Holding

Conditions Acute Respiratory Viral Infections
Interventions Ergoferon Placebo
Updated 14 times since 2017 Last updated: Aug 25, 2021 Started: Oct 7, 2016 Primary completion: Jan 9, 2019 Completion: Jan 9, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Acute Respiratory Viral Infections and is currently completed. Materia Medica Holding leads this study, which shows 14 recorded versions since 2016 — indicating substantial longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

~Feb 2017 – ~Apr 2017 · 59 days · monthly snapshot~Apr 2017 – ~Feb 2018 · 10 months · monthly snapshot~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Feb 2019 · 6 months · monthly snapshot~Feb 2019 – ~Jun 2019 · 4 months · monthly snapshot~Jun 2019 – ~May 2020 · 11 months · monthly snapshot~May 2020 – ~Jun 2020 · 31 days · monthly snapshot~Jun 2020 – ~Jan 2021 · 7 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Jul 2024 · 34 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Sep 2021 — Jul 2024 [monthly]

    Completed PHASE4

  5. Jan 2021 — Sep 2021 [monthly]

    Completed PHASE4

▶ Show 9 earlier versions

  1. Jun 2020 — Jan 2021 [monthly]

    Completed PHASE4

  2. May 2020 — Jun 2020 [monthly]

    Completed PHASE4

  3. Jun 2019 — May 2020 [monthly]

    Completed PHASE4

  4. Feb 2019 — Jun 2019 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed

  5. Aug 2018 — Feb 2019 [monthly]

    Recruiting PHASE4

  6. Jun 2018 — Aug 2018 [monthly]

    Recruiting PHASE4

  7. Feb 2018 — Jun 2018 [monthly]

    Recruiting PHASE4

  8. Apr 2017 — Feb 2018 [monthly]

    Recruiting PHASE4

    Status: Enrolling By Invitation → Recruiting

  9. Feb 2017 — Apr 2017 [monthly]

    Enrolling By Invitation PHASE4

    First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Materia Medica Holding
Data source: Materia Medica Holding

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations